Sensyne to Launch New Diabetes Remote Monitoring Software
Sensyne Health announced it has developed a new diabetes remote management system called “DBm-Health,” which focuses on people at risk of diabetes, pre-diabetes, T1DM, and T2DM. Sensyne plans to launch DBm-Health in the UK over the coming months with a US launch scheduled “toward the end of the current financial year” (March 31, 2021). Of note, Sensyne already offers other remote monitoring solutions for gestational diabetes, hypertension, heart failure, COPD, and COVID-19 (view Sensyne website). According to Sensyne, the new DBm-Health solution was created in response to increasing HCP demand for remote monitoring systems. Below, FENIX provides thoughts on the Sensyne DBm-Health solution, including insight into how some perceived deficiencies of the platform may preclude its use with patients and HCPs.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.